| DiaKine Therapeutics, Inc. Charlottesville, VA
DiaKine is a development-stage company commercializing novel immune modulators such as Lisofylline and related oral compounds into therapies for diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. The healthcare team provided extensive consulting throughout the company's formation - ranging from licensing of the technology to selection of its developer-CEO, together with early angel funding.
|
PluroGen Therapeutics, Inc.Charlottesville, VA
PluroGen is a biotechnology start-up focused on commercializing its proprietary technology platform of topical drug delivery and drug efficacy enhancement into novel innovative therapeutic products for wound management and healing. The Tall Oaks team provided regular and extensive support in the company's formative development period, primarily in connection with financial modeling, negotiations with potential corporate collaborators and selection of its experienced CEO-manager/developer. |
| Living MicroSystems, Inc. Richmond, VA
Living MicroSystems is a development stage entity with proprietary technology to select, image and analyze rare cells from whole blood. The highly qualified scientific inventors & developers are supported by an experienced CEO-manager who has completed a $5.3M Series A funding round that was led by Mohr Davidow Ventures. Tall Oaks' healthcare team advised extensively during the company's formation, contributing to development of the business plan, strategic and financial modeling, as well as support in the angel round funding. |
